This case series, including 15 Swedish individuals above the age of 60, provides an observational real-life experience of JAKi treatment in GCA for subjects where prednisolone alone was not sufficient or when the IL-6-blocking regimen was considered inappropriate. This evidence concerns the gene IL6 and temporal arteritis.